A combined vial of CJC-1295 without DAC (Modified GRF (1-29)), a 29-amino-acid GHRH analogue, and Ipamorelin (Aib-His-D-2Nal-D-Phe-Lys-NH2), a selective ghrelin receptor (GHS-R1a) agonist. The two act on separate receptors of the growth hormone axis and are frequently studied together.
Research Applications
Research applications include GHRH receptor and GHS-R1a co-stimulation models, pulsatile growth hormone release studies, and comparisons of combined versus single-agent secretagogue signalling.
Product Specifications
- Quantity: 5mg CJC-1295 No DAC + 5mg Ipamorelin per vial
- Form: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Molecular weight: 3367.9 Da (CJC-1295 No DAC), 711.9 Da (Ipamorelin)
- Storage: Store at -20°C. Reconstituted solution stable at 2-8°C for up to 14 days.
- CAS Number: 863288-34-0 (CJC-1295 No DAC), 170851-70-4 (Ipamorelin)
⚠️ For laboratory and research use only. Not intended for human or veterinary use.
